"Implantés au Mans (Sarthe - Pays de la Loire), les établissements de santé du Groupe ELSAN, le Centre Médico-Chirurgical du Mans et la clinique du Tertre Rouge offrent sur le site du Pôle Santé Sud, une prise en charge pluridisciplinaire articulée autour de 5 pôles : * Pôle chirurgical de pointe ; unités d’hospitalisation complète et ambulatoire, fast-track, unités de soins continus * Pôle médical ; médecine générale et gériatrique, unité cardiologie médicale et interventionnelle * Pôle santé-mentale psychiatrie ; unités d’hospitalisation complète et de jour * Pôle Femme-Mère-Enfants ; maternité niveau 2B, service de néonatologie, centre d’assistance médicale à la procréation de haute technicité, * Urgences 24/7"

During the past decade, Pôle Santé Sud conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pôle Santé Sud" #1 sponsor was "Centre Hospitalier de PAU" with 1 trials, followed by "Elsan" with 1 trials sponsored, "European Association of Urology Research Foundation" with 1 trials sponsored, "Laboratoires Coloplast S.A.S" with 1 trials sponsored and "UNICANCER" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pôle Santé Sud" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pôle Santé Sud" are "Lower Urinary Tract Symptoms" (1 trials), "Malignant Hypertension" (1 trials), "Ostomy" (1 trials), "Ovarian Epithelial Cancer Recurrent" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Pôle Santé Sud" in a lesser frequency.

Most popular intervention types in "Pôle Santé Sud" are "Other" (2 trials), "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "HIPEC" (1 trials), "Maximal cytoreductive surgery" (1 trials), "Questionnaires on Urinary Incontinence-, Sex Function- and Quality of Life (ICIQ-UI-SF, ICIQ-FLUTSsex, ICIQ-LUTSqol, PGI-I)" (1 trials), "Sensura Mio Bodyfit technology ostomy pouches" (1 trials) and "assessment of urinary function and erectil function before and after prostatectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pôle Santé Sud" are 2 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pôle Santé Sud". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Pôle Santé Sud, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pôle Santé Sud, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".